Related Experiment Video
Updated: May 18, 2026
09:21
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Should clot composition affect choice of endovascular therapy?
Brijesh P Mehta1, Raul G Nogueira
1Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Neurology
|September 26, 2012
Summary
Understanding the composition of blood clots removed during stroke treatment can improve endovascular therapy. This review examines clot histology, imaging, and ultrastructure from clinical and animal studies to guide better stroke interventions.
Area of Science:
- Neurology
- Interventional Radiology
- Pathology
Background:
- Endovascular therapy is a key treatment for acute ischemic stroke.
- Understanding thromboemboli composition is crucial for optimizing stroke therapies.
- Existing treatments like IV thrombolysis have limitations.
Purpose of the Study:
- To review clinical and experimental studies on the histology, imaging, and ultrastructure of thromboemboli.
- To correlate imaging findings with clot composition.
- To inform the development of improved endovascular strategies for stroke.
Main Methods:
- Review of existing literature on thromboemboli retrieved during acute ischemic stroke.
- Analysis of histological, imaging, and ultrastructural data.
- Inclusion of both human clinical and experimental animal studies.
Main Results:
- Thromboemboli show diverse compositions, influencing imaging characteristics.
- Histological analysis reveals varying proportions of fibrin, red blood cells, and platelets.
- Ultrastructural examination provides insights into clot architecture and mechanical properties.
Conclusions:
- Detailed knowledge of thromboemboli composition is essential for advancing endovascular stroke treatment.
- Correlation between imaging and histology can guide procedural choices.
- Further research into clot-specific therapies holds promise for stroke patients.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...